Peter Krajči

6.7k total citations · 1 hit paper
40 papers, 2.0k citations indexed

About

Peter Krajči is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Epidemiology. According to data from OpenAlex, Peter Krajči has authored 40 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 11 papers in Immunology and 10 papers in Epidemiology. Recurrent topics in Peter Krajči's work include Opioid Use Disorder Treatment (15 papers), Substance Abuse Treatment and Outcomes (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Peter Krajči is often cited by papers focused on Opioid Use Disorder Treatment (15 papers), Substance Abuse Treatment and Outcomes (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Peter Krajči collaborates with scholars based in Norway, Finland and India. Peter Krajči's co-authors include P Brandtzæg, Dag Kvale, Helge Scott, Ludvig M. Sollid, Per Brandtzæg, Trond S. Halstensen, Finn–Eirik Johansen, Torleiv O. Rognum, K Kett and Ellen M Nilsen and has published in prestigious journals such as The Journal of Experimental Medicine, Gastroenterology and Gut.

In The Last Decade

Peter Krajči

38 papers receiving 1.9k citations

Hit Papers

Immunobiology and immunopathology of human gut mucosa: Hu... 1989 2026 2001 2013 1989 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Krajči Norway 19 785 574 360 344 342 40 2.0k
José Antonio Garrote Spain 21 380 0.5× 626 1.1× 642 1.8× 306 0.9× 83 0.2× 91 1.6k
Deanna D. Nguyen United States 27 621 0.8× 765 1.3× 261 0.7× 474 1.4× 129 0.4× 72 2.5k
R L Clancy Australia 28 788 1.0× 498 0.9× 74 0.2× 267 0.8× 257 0.8× 100 2.6k
J C Rambaud France 21 237 0.3× 503 0.9× 541 1.5× 309 0.9× 200 0.6× 58 2.2k
Ulrike Strauch Germany 28 1.2k 1.6× 526 0.9× 201 0.6× 593 1.7× 80 0.2× 48 2.9k
Stanley Levin Israel 22 539 0.7× 385 0.7× 86 0.2× 294 0.9× 209 0.6× 101 1.8k
E Savilahti Finland 24 369 0.5× 377 0.7× 414 1.1× 186 0.5× 53 0.2× 53 1.6k
Karolien Claes Belgium 10 362 0.5× 615 1.1× 262 0.7× 1.2k 3.5× 135 0.4× 27 2.5k
Melanie Wong Australia 29 1.3k 1.7× 515 0.9× 81 0.2× 360 1.0× 177 0.5× 85 2.8k
John E. Hegarty Ireland 41 2.0k 2.6× 1.8k 3.1× 267 0.7× 336 1.0× 90 0.3× 106 5.0k

Countries citing papers authored by Peter Krajči

Since Specialization
Citations

This map shows the geographic impact of Peter Krajči's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Krajči with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Krajči more than expected).

Fields of papers citing papers by Peter Krajči

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Krajči. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Krajči. The network helps show where Peter Krajči may publish in the future.

Co-authorship network of co-authors of Peter Krajči

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Krajči. A scholar is included among the top collaborators of Peter Krajči based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Krajči. Peter Krajči is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haugaa, Kristina H., et al.. (2024). Effect on QTc interval by switching from methadone to equipotent R‐methadone dose in methadone maintenance treatment patients. Basic & Clinical Pharmacology & Toxicology. 134(4). 519–530.
2.
Tanum, Lars, Kristin Klemmetsby Solli, Zill-E-Huma Latif, et al.. (2017). Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence. JAMA Psychiatry. 74(12). 1197–1197. 178 indexed citations
3.
Reimer, Jens, Nat Wright, Lorenzo Somaini, et al.. (2015). The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus. European Addiction Research. 22(2). 99–106. 29 indexed citations
4.
Alho, Hannu, et al.. (2015). Misuse and diversion of agonist opioid treatment medicines: assessment of the scale of the problem and review of the changing environment for care in the Nordic countries. 17(5). 43–49. 1 indexed citations
5.
Alho, Hannu, Oscar D’Agnone, Peter Krajči, et al.. (2015). The extent of misuse and diversion of medication for agonist opioid treatment: A review and expert opinions. 17. 25–34. 6 indexed citations
6.
Krajči, Peter, et al.. (2000). Pseudo-Meigs" syndrom. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
7.
Johansen, Finn–Eirik, Marcela Pekna, Inger Natvig Norderhaug, et al.. (1999). Absence of Epithelial Immunoglobulin a Transport, with Increased Mucosal Leakiness, in Polymeric Immunoglobulin Receptor/Secretory Component–Deficient Mice. The Journal of Experimental Medicine. 190(7). 915–922. 307 indexed citations
8.
Nilsen, Ellen M, Finn–Eirik Johansen, Dag Kvale, Peter Krajči, & Per Brandtzæg. (1999). Different regulatory pathways employed in cytokine-enhanced expression of secretory component and epithelial HLA class I genes. European Journal of Immunology. 29(1). 168–179. 28 indexed citations
9.
Krajči, Peter, et al.. (1996). Secretory component mRNA and protein expression in colorectal adenomas and carcinomas. British Journal of Cancer. 73(12). 1503–1510. 10 indexed citations
10.
Moro, Itaru, Tomihisa Takahashi, Masatake Asano, et al.. (1995). Expression Of SC, IL-6 and TGF-β1 in Epithelial Cell Lines. Advances in experimental medicine and biology. 371A. 175–182. 4 indexed citations
11.
Kulseth, Mari Ann, Peter Krajči, Ola Myklebost, & Sissel Rogne. (1995). Cloning and Characterization of Two Forms of Bovine Polymeric Immunoglobulin Receptor cDNA. DNA and Cell Biology. 14(3). 251–256. 43 indexed citations
12.
Krajči, Peter, Dag Kvale, & Per Brandtzæg. (1995). Cloning, Chromosomal Localization, and Linkage Analysis of the Gene Encoding Human Transmembrane Secretory Component (The Poly-Ig Receptor). Advances in experimental medicine and biology. 371A. 617–623. 4 indexed citations
13.
Krajči, Peter, Kjetil Taskén, Dag Kvale, & P Brandtzæg. (1993). Interferon‐γ Stimulation of Messenger RNA for Human Secretory Component (poly‐Ig Receptor) Depends on Continuous Intermediate Protein Synthesis. Scandinavian Journal of Immunology. 37(2). 251–256. 23 indexed citations
14.
Krajči, Peter, Dag Kvale, Kjetil Taskén, & Per Brandtzæg. (1992). Molecular cloning and exon‐intron mapping of the gene encoding human transmembrane secretory component (the poly‐Ig receptor). European Journal of Immunology. 22(9). 2309–2315. 46 indexed citations
15.
Kvale, Dag, Peter Krajči, & P Brandtzæg. (1992). Expression and Regulation of Adhesion Molecules ICAM‐1 (CD54) and LFA‐3 (CD58) in Human Intestinal Epithelial Cell Lines. Scandinavian Journal of Immunology. 35(6). 669–676. 100 indexed citations
16.
Solberg, Rigmor, Pertti Sistonen, D. Bérubé, et al.. (1992). Mapping of the regulatory subunits RIβ and RIIβ of cAMP-Dependent protein kinase genes on human chromosome 7. Genomics. 14(1). 63–69. 15 indexed citations
17.
Krajči, Peter, Tobias Gedde‐Dahl, Bjørn Høyheim, et al.. (1992). The gene encoding human transmembrane secretory component (locus PIGR) is linked to D1S58 on chromosome 1. Human Genetics. 90(3). 215–219. 13 indexed citations
18.
Brandtzæg, Per, Trond S. Halstensen, Henrik S. Huitfeldt, et al.. (1992). Epithelial Expression of HLA, Secretory Component (Poly‐Ig Receptor), and Adhesion Molecules in the Human Alimentary Tracta. Annals of the New York Academy of Sciences. 664(1). 157–179. 66 indexed citations
19.
Krajči, Peter, Rigmor Solberg, Mårten Sandberg, et al.. (1989). Molecular cloning of the human transmembrane secretory component (poly-Ig receptor) and its mRNA expression in human tissues. Biochemical and Biophysical Research Communications. 158(3). 783–789. 87 indexed citations
20.
Brandtzæg, P, Trond S. Halstensen, K Kett, et al.. (1989). Immunobiology and immunopathology of human gut mucosa: Humoral immunity and intraepithelial lymphocytes. Gastroenterology. 97(6). 1562–1584. 409 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026